The mitochondrial master regulator gene PGC1alpha in novel sporadic melanoma cell lines: correlations with BRAF mutational status
Gabriella Guida(University of Bari Aldo Moro), Michele Guida(Istituto Tumori Bari), Stefania Guida(Vita-Salute San Raffaele University), Anna Ferretta(University of Bari Aldo Moro), Amalia Azzariti(Istituto Tumori Bari), Rossella Labarile(Institute for Chemical and Physical Processes), Sabino Strippoli(Istituto Tumori Bari), Anna Albano(Istituto Tumori Bari), Raffaele Filotico(University of Bari Aldo Moro), Tiziana Cocco(University of Bari Aldo Moro), Paola Zanna(Universidad de Murcia), Mari C Turpin Sevilla(University of Bari Aldo Moro), Immacolata Maida(University of Bari Aldo Moro), Stefania Tommasi(Istituto Tumori Bari), Letizia Porcelli(Istituto Tumori Bari)
Cited by 3
Related Papers
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated <i>BRAF</i>-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial
|Journal of Clinical Oncology|2022|231
Accuracy in melanoma detection: A 10-year multicenter survey
|Journal of the American Academy of Dermatology|2011|209
The E6 and E7 Proteins of the Cutaneous Human Papillomavirus Type 38 Display Transforming Properties
|Journal of Virology|2003|187
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort
|Journal of Translational Medicine|2014|164